Early Nasopharyngeal Carcinoma Screening Program

Early-stage nasopharyngeal carcinoma often presents with no obvious symptoms and is easily overlooked. Nasopharyngeal carcinoma screening allows high-risk individuals to detect the disease before any symptoms appear, enabling them to receive appropriate treatment. Since there is currently no vaccine to prevent nasopharyngeal carcinoma, early screening is an effective way to significantly increase the chances of successful treatment. This physical examination program utilizes next-generation DNA sequencing technology for early nasopharyngeal carcinoma screening; the entire process is non-invasive and convenient, allowing you to understand your disease risk and your own health status.

Early nasopharyngeal carcinoma screening program (single test)

The purpose of nasopharyngeal carcinoma screening is to identify patients in the early stages of the disease, thereby increasing the likelihood of successful treatment and survival rates. Some symptoms of early nasopharyngeal carcinoma can be easily confused with those of a common cold, so early screening can effectively identify patients and allow them to receive treatment as soon as possible, greatly improving the chances of a successful cure and survival rate. Modern nasopharyngeal carcinoma screening only requires a blood test and is non-invasive. Even without obvious symptoms, next-generation sequencing technology can accurately identify "hidden" patients.

Suitable candidates for nasopharyngeal carcinoma screening

Individuals at risk of nasopharyngeal carcinoma (including those with a family history of the disease) or those who intend to undergo an annual physical examination.